Overview

Bioequivalency Study of Losartan Potassium 100 mg Tablet Under Fasted Conditions

Status:
Completed
Trial end date:
2004-08-01
Target enrollment:
Participant gender:
Summary
The objective of this study was to prove the bioequivalence of Losartan Potassium 100 tablet under fasted conditions.
Phase:
N/A
Details
Lead Sponsor:
Roxane Laboratories
Treatments:
Losartan